Lv1
20 积分 2025-07-10 加入
Resistance to Selective FLT3 Inhibitors, Driven by FLT3 Ligand and FLT3 Point Mutations, Can Be Overcome with the Dual FLT3-Aurora Kinase Inhibitor CCT241736,
2个月前
已关闭
FLT3 Inhibitor Treatment Increases FLT3 Expression That Exposes FLT3-ITD+ AML Blasts to Elimination By FLT3 CAR-T Cells
2个月前
已关闭
CLK2 Regulates the KEAP1/NRF2 and p53 Pathways to Suppress Ferroptosis in Colorectal Cancer
4个月前
已完结
MDM2 inhibition: an important step forward in cancer therapy
8个月前
已完结
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
9个月前
已完结
Transfecting Macrophages
9个月前
已完结
Pharmacological reactivation of p53 in the era of precision anticancer medicine
9个月前
已完结
Design of Murine Double Minute 2 Proteolysis Targeting Chimera Degraders with a Built-In Tumor-Targeting Ability
10个月前
已完结
皖公网安备34019202002308
